Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences EV-based Diagnostics, Delivery & Therapeutics

Mei He's Biography

Mei He, Assistant Professor, University of Kansas and Chief Science Officer of Clara Biotech

Dr. He is a tenure-track assistant professor at the University of Kansas. She received her PhD degree from the University of Alberta and postdoctoral training from the University of California, Berkeley. She is the vice-chair of the ASABE Biosensor program and the Councilor of the American Electrophoresis Society. Dr. He is also the founder of Clara Biotech Inc. and the founder committee for the MidWest 3D technology society. Dr. He Received NIH Maximizing Investigator’s Research Award for Early Stage Investigators in 2019. She also received the Lab-on-a-Chip Outstanding Reviewer for the year of 2018 and Emerging Investigator in 2019. Her publications for investigating diagnostic and therapeutic roles of exosomes in the journal of Lab Chip received the Most Download Articles of 2016, Inside Cover Story, and the Featured Cover Story of 2018, and also received 2018 SLAS Technology Readers Choice Award. Her research interests include biomedical microfluidic devices and sensing approaches, 3D biomaterials, and nanodelivery, employed in programming and monitoring biomimetic immunity associated with extracellular vesicles.

Dr. He is also Chief Science Officer of Clara Biotech.

Mei He Image

High-Throughput Engineering Exosomes For Precision Immunotherapy

Tuesday, 18 February 2020 at 11:00

Add to Calendar ▼2020-02-18 11:00:002020-02-18 12:00:00Europe/LondonHigh-Throughput Engineering Exosomes For Precision ImmunotherapyEV-based Diagnostics, Delivery and Therapeutics in Coronado Island, CaliforniaCoronado Island,

Studying extracellular vesicles (EV), particularly exosomes, is holding great promise. With intrinsic molecular payload and biodegradability, molecular engineering of exosomes opens new avenues for mediating cellular responses and developing novel nano-delivery systems in precision immunotherapy. We will report several novel approaches including microfluidic technology and nanotechnology developed in our research group for engineering exosomes as nanodelivery system employed in advancing precision immunotherapy.

Add to Calendar ▼2020-02-17 00:00:002020-02-18 00:00:00Europe/LondonEV-based Diagnostics, Delivery and TherapeuticsEV-based Diagnostics, Delivery and Therapeutics in Coronado Island, CaliforniaCoronado Island,